New knee shot aims to ease arthritis pain without surgery
NCT ID NCT07580716
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called Allocetra, given as a shot into the knee joint, for people aged 64+ with moderate-to-severe knee osteoarthritis. The goal is to see if it reduces pain and improves function better than a placebo. About 270 participants will be followed for 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY KNEE OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centrum Medyczne PLEJADY
NOT_YET_RECRUITINGKrakow, 30-363, Poland
-
DC-MED Michal Kowalski S.K. Radom
NOT_YET_RECRUITINGRadom, 26-610, Poland
-
DC-MED Michal Kowalski S.K. Swidnica
NOT_YET_RECRUITINGSwidnica, 58-100, Poland
-
DelRicht Research @ Touro Medical Center
RECRUITINGNew Orleans, Louisiana, 70115, United States
-
Etg Justmed
NOT_YET_RECRUITINGWarsaw, 01-696, Poland
-
Etg Warszawa
NOT_YET_RECRUITINGWarsaw, 02-677, Poland
-
Future Medical Research
RECRUITINGLongwood, Florida, 32750, United States
-
Medyczne Centrum Hetmańska
NOT_YET_RECRUITINGPoznan, 60-218, Poland
-
Migre Polskie Centrum
NOT_YET_RECRUITINGWroclaw, 52-210, Poland
-
NZOZ Bif-Med. s.c
NOT_YET_RECRUITINGBytom, 41-902, Poland
-
Oakland Medical Research
RECRUITINGTroy, Michigan, 48085, United States
-
Reumedika sp. z o.o.
NOT_YET_RECRUITINGPoznan, 60-446, Poland
-
Sanos Clinic Gandrup
RECRUITINGGandrup, 9362, Denmark
-
Sanos Clinic Herlev
RECRUITINGHerlev, 2730, Denmark
-
Sanos Clinic Vejle
RECRUITINGVejle, 7100, Denmark
-
South Florida Research Phase I-IV
RECRUITINGMiami, Florida, 33166, United States
-
Vita Longa Sp. z o.o.
NOT_YET_RECRUITINGKatowice, 40-748, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.